radium-223 dichloride Articles

FDA priority review for Algeta and Bayer's prostate cancer agent radium-223

14 February 2013

US NRC rules sites can procure radium-223 dichloride for Algeta/Bayer's prostate cancer candidate

14 January 2013

Showing 1-2 of 2 articles

Go to beginning

Previous

1

Next

Go to end

Is failure to adopt business process management putting the pharma industry at risk?
New Zealand declines Alexion's funding application for Solaris
HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
Elan makes "transformational" acquisitions and a divestment